Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes
Obesity is a pathophysiological condition where excess free fatty acids (FFA) target and promote the dysfunctioning of insulin sensitive tissues and of pancreatic β cells. This leads to the dysregulation of glucose homeostasis, which culminates in the onset of type 2 diabetes (T2D). FFA, which accum...
Main Authors: | Jeanne Guitton, Cécile L. Bandet, Mohamed L. Mariko, Sophie Tan-Chen, Olivier Bourron, Yacir Benomar, Eric Hajduch, Hervé Le Stunff |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1682 |
Similar Items
-
Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology
by: Sophie Tan-Chen, et al.
Published: (2020-08-01) -
The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
by: Kana Masuda-Kuroki, et al.
Published: (2023-09-01) -
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
by: Sara Grassi, et al.
Published: (2019-07-01) -
Neurological Consequences of Sphingosine Phosphate Lyase Insufficiency
by: Krishan B. Atreya, et al.
Published: (2022-09-01) -
Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface
by: Kana Masuda-Kuroki, et al.
Published: (2022-05-01)